Simultaneous determination of benserazide and levodopa by capillary electrophoresis–chemiluminescence using an improved interface

A capillary electrophoresis coupling with indirect chemiluminescence detection method for the simultaneous determination of benserazide and levodopa has been developed. The detection interface was improved to simplify the capillary electrophoresis–chemiluminescence (CE–CL) system and the features of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Chromatography A 2006-10, Vol.1131 (1), p.289-292
Hauptverfasser: He, Wei-Wei, Zhou, Xing-Wang, Lu, Jian-Quan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 292
container_issue 1
container_start_page 289
container_title Journal of Chromatography A
container_volume 1131
creator He, Wei-Wei
Zhou, Xing-Wang
Lu, Jian-Quan
description A capillary electrophoresis coupling with indirect chemiluminescence detection method for the simultaneous determination of benserazide and levodopa has been developed. The detection interface was improved to simplify the capillary electrophoresis–chemiluminescence (CE–CL) system and the features of this improved interface were illustrated in this paper. The CE–CL conditions for the simultaneous determination of benserazide and levodopa were optimized. Under the optimal conditions, the CL intensity was linear with concentrations of levodopa in the range of 1.0 to 100.0 μg ml −1, and benserazide in the range of 10.0 to 1000 μg ml −1, respectively. The detection limits (S/N = 3) in turn were 1.85 μg ml −1 for BS and 0.12 μg ml −1 for L-dopa with relative standard deviations of less than 3%. The proposed method has been successfully applied to the determination of benserazide and levodopa in medopar tablets and spiked urine samples, demonstrating the feasibility and reliability of the proposed method.
doi_str_mv 10.1016/j.chroma.2006.08.071
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68939876</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021967306016414</els_id><sourcerecordid>68939876</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-fb694a520e223ba8eec74c1b36aac668aa6ab0fcfc83104c90c82921597359fe3</originalsourceid><addsrcrecordid>eNp9kM1u1DAUhbMA0dLyBgh5A7sJtjPjnw0SqoAiVWJBu7Zubq4Zj5I42MlIZYXEI_QNeZJ6mJG6Y-XNd4_P-arqteC14EK939W4TXGAWnKuam5qrsWz6pxzKVZW6easepnzjnOhuZYvqjOhrLZC6_Pqz_cwLP0MI8Uls45mSkMYYQ5xZNGzlsZMCX6FjhiMHetpH7s4AWvvGcIU-h7SPaOecE5x2sZEOeS_vx9wS0PolxJFGWlEYksO44-SwcIwpbinjoWxfOYB6bJ67qHP9Or0XlR3nz_dXl2vbr59-Xr18WaFjeXzyrfKrmEjOUnZtGCIUK9RtI0CQKUMgIKWe_RoGsHXaDkaaaXYWN1srKfmonp3zC0Ffi6UZzeE0q5s-LfeKWMba7Qq4PoIYoo5J_JuSmEoS53g7iDc7dxRuDsId9y4IrycvTnlL-1A3dPRyXYB3p4AyAi9TzBiyE-cEbqwsnAfjhwVG_tAyWUMB4tdSMW062L4f5NHzGSoRw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68939876</pqid></control><display><type>article</type><title>Simultaneous determination of benserazide and levodopa by capillary electrophoresis–chemiluminescence using an improved interface</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>He, Wei-Wei ; Zhou, Xing-Wang ; Lu, Jian-Quan</creator><creatorcontrib>He, Wei-Wei ; Zhou, Xing-Wang ; Lu, Jian-Quan</creatorcontrib><description>A capillary electrophoresis coupling with indirect chemiluminescence detection method for the simultaneous determination of benserazide and levodopa has been developed. The detection interface was improved to simplify the capillary electrophoresis–chemiluminescence (CE–CL) system and the features of this improved interface were illustrated in this paper. The CE–CL conditions for the simultaneous determination of benserazide and levodopa were optimized. Under the optimal conditions, the CL intensity was linear with concentrations of levodopa in the range of 1.0 to 100.0 μg ml −1, and benserazide in the range of 10.0 to 1000 μg ml −1, respectively. The detection limits (S/N = 3) in turn were 1.85 μg ml −1 for BS and 0.12 μg ml −1 for L-dopa with relative standard deviations of less than 3%. The proposed method has been successfully applied to the determination of benserazide and levodopa in medopar tablets and spiked urine samples, demonstrating the feasibility and reliability of the proposed method.</description><identifier>ISSN: 0021-9673</identifier><identifier>DOI: 10.1016/j.chroma.2006.08.071</identifier><identifier>PMID: 16979177</identifier><identifier>CODEN: JOCRAM</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Analysis ; Benserazide ; Benserazide - analysis ; Biological and medical sciences ; Capillary electrophoresis ; Chemiluminescence ; Electrophoresis, Capillary - instrumentation ; Electrophoresis, Capillary - methods ; General pharmacology ; Indirect detection ; Interface ; Levodopa ; Levodopa - analysis ; Luminescent Measurements - instrumentation ; Luminescent Measurements - methods ; Medical sciences ; Pharmacology. Drug treatments ; Reproducibility of Results</subject><ispartof>Journal of Chromatography A, 2006-10, Vol.1131 (1), p.289-292</ispartof><rights>2006 Elsevier B.V.</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-fb694a520e223ba8eec74c1b36aac668aa6ab0fcfc83104c90c82921597359fe3</citedby><cites>FETCH-LOGICAL-c390t-fb694a520e223ba8eec74c1b36aac668aa6ab0fcfc83104c90c82921597359fe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0021967306016414$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18171692$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16979177$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>He, Wei-Wei</creatorcontrib><creatorcontrib>Zhou, Xing-Wang</creatorcontrib><creatorcontrib>Lu, Jian-Quan</creatorcontrib><title>Simultaneous determination of benserazide and levodopa by capillary electrophoresis–chemiluminescence using an improved interface</title><title>Journal of Chromatography A</title><addtitle>J Chromatogr A</addtitle><description>A capillary electrophoresis coupling with indirect chemiluminescence detection method for the simultaneous determination of benserazide and levodopa has been developed. The detection interface was improved to simplify the capillary electrophoresis–chemiluminescence (CE–CL) system and the features of this improved interface were illustrated in this paper. The CE–CL conditions for the simultaneous determination of benserazide and levodopa were optimized. Under the optimal conditions, the CL intensity was linear with concentrations of levodopa in the range of 1.0 to 100.0 μg ml −1, and benserazide in the range of 10.0 to 1000 μg ml −1, respectively. The detection limits (S/N = 3) in turn were 1.85 μg ml −1 for BS and 0.12 μg ml −1 for L-dopa with relative standard deviations of less than 3%. The proposed method has been successfully applied to the determination of benserazide and levodopa in medopar tablets and spiked urine samples, demonstrating the feasibility and reliability of the proposed method.</description><subject>Analysis</subject><subject>Benserazide</subject><subject>Benserazide - analysis</subject><subject>Biological and medical sciences</subject><subject>Capillary electrophoresis</subject><subject>Chemiluminescence</subject><subject>Electrophoresis, Capillary - instrumentation</subject><subject>Electrophoresis, Capillary - methods</subject><subject>General pharmacology</subject><subject>Indirect detection</subject><subject>Interface</subject><subject>Levodopa</subject><subject>Levodopa - analysis</subject><subject>Luminescent Measurements - instrumentation</subject><subject>Luminescent Measurements - methods</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Reproducibility of Results</subject><issn>0021-9673</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1u1DAUhbMA0dLyBgh5A7sJtjPjnw0SqoAiVWJBu7Zubq4Zj5I42MlIZYXEI_QNeZJ6mJG6Y-XNd4_P-arqteC14EK939W4TXGAWnKuam5qrsWz6pxzKVZW6easepnzjnOhuZYvqjOhrLZC6_Pqz_cwLP0MI8Uls45mSkMYYQ5xZNGzlsZMCX6FjhiMHetpH7s4AWvvGcIU-h7SPaOecE5x2sZEOeS_vx9wS0PolxJFGWlEYksO44-SwcIwpbinjoWxfOYB6bJ67qHP9Or0XlR3nz_dXl2vbr59-Xr18WaFjeXzyrfKrmEjOUnZtGCIUK9RtI0CQKUMgIKWe_RoGsHXaDkaaaXYWN1srKfmonp3zC0Ffi6UZzeE0q5s-LfeKWMba7Qq4PoIYoo5J_JuSmEoS53g7iDc7dxRuDsId9y4IrycvTnlL-1A3dPRyXYB3p4AyAi9TzBiyE-cEbqwsnAfjhwVG_tAyWUMB4tdSMW062L4f5NHzGSoRw</recordid><startdate>20061027</startdate><enddate>20061027</enddate><creator>He, Wei-Wei</creator><creator>Zhou, Xing-Wang</creator><creator>Lu, Jian-Quan</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20061027</creationdate><title>Simultaneous determination of benserazide and levodopa by capillary electrophoresis–chemiluminescence using an improved interface</title><author>He, Wei-Wei ; Zhou, Xing-Wang ; Lu, Jian-Quan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-fb694a520e223ba8eec74c1b36aac668aa6ab0fcfc83104c90c82921597359fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Analysis</topic><topic>Benserazide</topic><topic>Benserazide - analysis</topic><topic>Biological and medical sciences</topic><topic>Capillary electrophoresis</topic><topic>Chemiluminescence</topic><topic>Electrophoresis, Capillary - instrumentation</topic><topic>Electrophoresis, Capillary - methods</topic><topic>General pharmacology</topic><topic>Indirect detection</topic><topic>Interface</topic><topic>Levodopa</topic><topic>Levodopa - analysis</topic><topic>Luminescent Measurements - instrumentation</topic><topic>Luminescent Measurements - methods</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Reproducibility of Results</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>He, Wei-Wei</creatorcontrib><creatorcontrib>Zhou, Xing-Wang</creatorcontrib><creatorcontrib>Lu, Jian-Quan</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of Chromatography A</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>He, Wei-Wei</au><au>Zhou, Xing-Wang</au><au>Lu, Jian-Quan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Simultaneous determination of benserazide and levodopa by capillary electrophoresis–chemiluminescence using an improved interface</atitle><jtitle>Journal of Chromatography A</jtitle><addtitle>J Chromatogr A</addtitle><date>2006-10-27</date><risdate>2006</risdate><volume>1131</volume><issue>1</issue><spage>289</spage><epage>292</epage><pages>289-292</pages><issn>0021-9673</issn><coden>JOCRAM</coden><abstract>A capillary electrophoresis coupling with indirect chemiluminescence detection method for the simultaneous determination of benserazide and levodopa has been developed. The detection interface was improved to simplify the capillary electrophoresis–chemiluminescence (CE–CL) system and the features of this improved interface were illustrated in this paper. The CE–CL conditions for the simultaneous determination of benserazide and levodopa were optimized. Under the optimal conditions, the CL intensity was linear with concentrations of levodopa in the range of 1.0 to 100.0 μg ml −1, and benserazide in the range of 10.0 to 1000 μg ml −1, respectively. The detection limits (S/N = 3) in turn were 1.85 μg ml −1 for BS and 0.12 μg ml −1 for L-dopa with relative standard deviations of less than 3%. The proposed method has been successfully applied to the determination of benserazide and levodopa in medopar tablets and spiked urine samples, demonstrating the feasibility and reliability of the proposed method.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>16979177</pmid><doi>10.1016/j.chroma.2006.08.071</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0021-9673
ispartof Journal of Chromatography A, 2006-10, Vol.1131 (1), p.289-292
issn 0021-9673
language eng
recordid cdi_proquest_miscellaneous_68939876
source MEDLINE; Elsevier ScienceDirect Journals
subjects Analysis
Benserazide
Benserazide - analysis
Biological and medical sciences
Capillary electrophoresis
Chemiluminescence
Electrophoresis, Capillary - instrumentation
Electrophoresis, Capillary - methods
General pharmacology
Indirect detection
Interface
Levodopa
Levodopa - analysis
Luminescent Measurements - instrumentation
Luminescent Measurements - methods
Medical sciences
Pharmacology. Drug treatments
Reproducibility of Results
title Simultaneous determination of benserazide and levodopa by capillary electrophoresis–chemiluminescence using an improved interface
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T03%3A21%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Simultaneous%20determination%20of%20benserazide%20and%20levodopa%20by%20capillary%20electrophoresis%E2%80%93chemiluminescence%20using%20an%20improved%20interface&rft.jtitle=Journal%20of%20Chromatography%20A&rft.au=He,%20Wei-Wei&rft.date=2006-10-27&rft.volume=1131&rft.issue=1&rft.spage=289&rft.epage=292&rft.pages=289-292&rft.issn=0021-9673&rft.coden=JOCRAM&rft_id=info:doi/10.1016/j.chroma.2006.08.071&rft_dat=%3Cproquest_cross%3E68939876%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68939876&rft_id=info:pmid/16979177&rft_els_id=S0021967306016414&rfr_iscdi=true